In January, the American Health Law Association (AHLA) published its annual “Top 10 Issues in Health Law” article in Health Law Connections magazine. The article covers issues such as reproductive rights, telehealth, antitrust, data privacy, long-term care reform, and more. Similar to last year’s article, AHLA will run a series of podcasts addressing each of the 10 topics. In this series, PYA thought leaders join other health law experts for in-depth discussions on the impact such issues have on the healthcare industry.
Below are the topics for the series.
 |
Reproductive Health Rights in a Post-Roe Era PYA Managing Principal of Valuation Services Carol Carden speaks with Devon Minnick, Associate, Epstein Becker Green PC, about the continued effects of the Dobbs decision on the health law landscape. They discuss state efforts to restrict or protect abortion access, conflicts between state and federal law, and the impact on providers and employers. |
 |
Health Care Antitrust Enforcement Trends and Outlook PYA Managing Principal of Consulting Services David McMillan speaks with Dionne Lomax, Managing Director of Antitrust and Trade Regulation at Affiliated Monitors, Inc., about trends in antitrust enforcement, including recent FTC activity, a major uptick in hiring in the Antitrust Division, and potential areas of focus (“no poach” agreements, non-competes, etc.) |
 |
Telehealth Trends: What to Watch PYA Principal Martie Ross speaks with Jeremy Sherer, a partner at Hooper Lundy & Bookman PC, about increased government scrutiny surrounding telehealth, the expiration of COVID-19 waivers and Medicare coverage, in-person exam requirements for prescribing controlled substances, and legislative/regulatory updates. |
 |
Implications of the CMS Framework for Health Equity PYA Principal Deborah Biggs speaks with Dawn Hunter, Network for Public Health Law’s Southeastern Region Director, about health equity and the CMS vision (current, on the horizon, big picture) for the framework for promoting health equity across its programs, new data collection/reporting requirements, incentives for providers through payment system changes to promote health equity, and new value-based reimbursement models. |
 |
Fraud & Abuse Issues to Watch PYA Chief Compliance Officer Shannon Sumner speaks with Chris Sabis, a member of Sherrard Roe Voigt & Harbison PLC and the head of its Government Compliance & Investigations group. They discuss data mining (OIG/DOJ increasing use of data to identify/pursue outliers), enforcement trends, and subregulatory guidance (Brand Memo versus Garland Memo and the repeal of Trump-era rules). |
 |
New Year, New (and Old) Data Privacy Requirements PYA Principal Barry Mathis speaks with Valerie Breslin Montague, a partner with Nixon Peabody LLP, about new data privacy laws and regulations for 2023, the expiration of the PHE, the HIPAA proposed rule, FTC enforcement, healthcare tracking apps, and state law. |
 |
Long Term Care Reforms PYA Principal Anna Bhat speaks with William Hopkins of Spencer Fane LLP about long-term care (LTC) reforms and the administration’s focus on improving transparency in and oversight of LTC facilities from minimum staffing ratios and resident crowding to strengthening the skilled nursing value-based purchasing program and reinforcing safeguards against unnecessary medications and treatments. |
 |
It Costs How Much? Drug Pricing and the Inexorable Shift to Non-Institutional Care Settings PYA Principal Jane Jerzak speaks with Todd Nova, a partner with Hall Render Killian Heath & Lyman PC, about 340B drug reimbursement and the Inflationary Reduction Act, including Medicare negotiating drug prices, insulin price caps, and Part D revisions. |
 |
ESG-Related Matters PYA Principal Deborah Biggs speaks with Michael W. Peregrine, a partner at McDermott Will & Emery LLP, and Anne M. Murphy, a partner at ArentFox Schiff LLP, about the application of environmental, social, and governance (ESG)-related matters across the healthcare industry. They discuss the definition and scope of ESG, HHS involvement, and more. |
 |
Research-Related Developments to Watch PYA Principal Tynan Kugler speaks with Rebecca Schaefer, a partner at K&L Gates LLP, about research—an area of dynamic policy initiatives and regulatory change. They discuss a new model for vaccine development, the new biomedical research agency (ARPA-H), President Biden’s Cancer Moonshot Initiative, and the major update to the Common Rule. |
If you would like assistance with any of these topics or any matter involving strategy and integration, compliance, or valuation, one of our executive contacts would be happy to assist. You may email them below, or call (800) 270-9629.
